(0.26%) 5 261.95 points
(0.22%) 39 848 points
(0.01%) 16 401 points
(2.13%) $83.08
(1.69%) $1.747
(1.31%) $2 241.70
(0.85%) $24.96
(1.26%) $921.15
(0.38%) $0.927
(0.80%) $10.85
(0.12%) $0.792
(0.14%) $92.57
4 days till quarter result
(bmo 2024-04-01)
Expected move: +/- 14.72%
@ $5.29
Issued: 14 Feb 2024 @ 14:56
Return: 0.00%
Previous signal: Feb 13 - 15:19
Previous signal:
Return: 1.15 %
Live Chart Being Loaded With Signals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States...
Stats | |
---|---|
Today's Volume | 41 814.00 |
Average Volume | 234 724 |
Market Cap | 68.70M |
EPS | $-0.270 ( 2023-11-09 ) |
Next earnings date | ( $0 ) 2024-04-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 6.22 |
ATR14 | $0.0180 (0.34%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-28 | Tarriff Scott | Sell | 2 119 | Common Stock |
2024-02-27 | Cahill Brian Joseph | Buy | 3 800 | Common Stock |
2024-02-27 | Cahill Brian Joseph | Sell | 1 589 | Common Stock |
2024-02-27 | Tarriff Scott | Buy | 12 950 | Common Stock |
2024-02-27 | Tarriff Scott | Sell | 3 154 | Common Stock |
INSIDER POWER |
---|
59.06 |
Last 99 transactions |
Buy: 818 589 | Sell: 362 958 |
Volume Correlation
Eagle Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
RMRM | 0.965 |
SVAC | 0.963 |
PINC | 0.943 |
TLGT | 0.939 |
WMG | 0.936 |
TUEM | 0.926 |
PAIC | 0.924 |
JRJC | 0.923 |
IEP | 0.922 |
COLM | 0.918 |
10 Most Negative Correlations | |
---|---|
AMRB | -0.956 |
NETE | -0.951 |
MORF | -0.949 |
AVDL | -0.931 |
WPRT | -0.928 |
RXDX | -0.927 |
NYMTN | -0.92 |
COKE | -0.919 |
FLMN | -0.919 |
KBWD | -0.917 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eagle Pharmaceuticals Inc Correlation - Currency/Commodity
Eagle Pharmaceuticals Inc Financials
Annual | 2022 |
Revenue: | $316.61M |
Gross Profit: | $221.67M (70.01 %) |
EPS: | $2.76 |
Q2 | 2023 |
Revenue: | $64.65M |
Gross Profit: | $47.79M (73.92 %) |
EPS: | $0.390 |
Q1 | 2023 |
Revenue: | $66.31M |
Gross Profit: | $49.01M (73.91 %) |
EPS: | $0.440 |
Q4 | 2022 |
Revenue: | $60.70M |
Gross Profit: | $40.83M (67.27 %) |
EPS: | $0.630 |
Financial Reports:
No articles found.
Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators